Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/29/21
End: 04/12/24
Due: 04/12/25
Phase: N/A
Priority: Normal
Start: 02/17/20
End: 05/17/23
Due: 05/17/24
Phase: N/A
Priority: Normal
Start: 05/24/22
End: 04/12/24
Due: 04/12/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product. | NCT05645744 | Mustang Bio | user2@example.com | None | 2021-09-29 | 2024-04-12 | 2025-04-12 | - | - | 2025-07-14 |
| Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN. | NCT04109482 | Mustang Bio | user2@example.com | None | 2020-02-17 | 2023-05-17 | 2024-05-17 | - | - | 2025-07-14 |
| Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL | NCT05360238 | Mustang Bio | user2@example.com | None | 2022-05-24 | 2024-04-12 | 2025-04-12 | - | - | 2025-07-14 |